Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tito Fojo

Showing results (171-180 of 237) with videos related to

Pageof 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Evidence for microtubule target engagement in tumors of patients receiving ixabepiloneSen H Zhuang, Y Elizabeth Hung, Laura Hung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphomaRichard L Piekarz, A Robin Frye, John J Wright, et al.
JCO Clinical Cancer Informatics|September 15, 2023
Modeling Tumor Growth Using Partly Conditional Survival Models: A Case Study in Colorectal CancerJessica R Flynn, Michael Curry, Binsheng Zhao, et al.
Clinical Endocrinology|March 22, 2016
Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort studyHenrique Vara Luiz, Mary Jane Tanchee, Maria G Pavlatou, et al.
Cellular and Molecular Neurobiology|April 7, 2018
Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical ChemotherapyIrfan Jawed, Margarita Velarde, Roland Därr, et al.
Seminars in Oncology|September 2, 2022
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. VeteransHarshraj Leuva, Mengxi Zhou, Norbert Brau, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 3, 2015
CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDYHana Turkova, Tamara Prodanov, Marek Maly, et al.
JAMA Network Open|November 4, 2025
Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate CancerHarshraj Leuva, Mengxi Zhou, Benjamin A Teply, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbineJame Abraham, Maureen Edgerly, Richard Wilson, et al.
Journal of Cancer Research and Clinical Oncology|April 5, 2017
SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlationsIvana Jochmanova, Katherine I Wolf, Kathryn S King, et al.
Pageof 24

Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Evidence for microtubule target engagement in tumors of patients receiving ixabepiloneSen H Zhuang, Y Elizabeth Hung, Laura Hung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphomaRichard L Piekarz, A Robin Frye, John J Wright, et al.
JCO Clinical Cancer Informatics|September 15, 2023
Modeling Tumor Growth Using Partly Conditional Survival Models: A Case Study in Colorectal CancerJessica R Flynn, Michael Curry, Binsheng Zhao, et al.
Clinical Endocrinology|March 22, 2016
Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort studyHenrique Vara Luiz, Mary Jane Tanchee, Maria G Pavlatou, et al.
Cellular and Molecular Neurobiology|April 7, 2018
Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical ChemotherapyIrfan Jawed, Margarita Velarde, Roland Därr, et al.
Seminars in Oncology|September 2, 2022
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. VeteransHarshraj Leuva, Mengxi Zhou, Norbert Brau, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 3, 2015
CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDYHana Turkova, Tamara Prodanov, Marek Maly, et al.
JAMA Network Open|November 4, 2025
Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate CancerHarshraj Leuva, Mengxi Zhou, Benjamin A Teply, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbineJame Abraham, Maureen Edgerly, Richard Wilson, et al.
Journal of Cancer Research and Clinical Oncology|April 5, 2017
SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlationsIvana Jochmanova, Katherine I Wolf, Kathryn S King, et al.
Pageof 24